Cite
MLA Citation
Eva Prescott et al.. “Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study.” International journal of cardiology, vol. 365, 2022, pp. 34–40. http://access.bl.uk/ark:/81055/vdc_100163063665.0x000051